Royalty Pharma PLC (RPRX)
27.99
-0.27
(-0.96%)
USD |
NASDAQ |
May 08, 16:00
27.99
0.00 (0.00%)
After-Hours: 16:32
Royalty Pharma Price: 27.99 for May 8, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 07, 2024 | 28.50 | 28.58 | 28.10 | 28.26 | 2.185M |
May 06, 2024 | 28.41 | 28.73 | 28.36 | 28.49 | 1.861M |
May 03, 2024 | 28.66 | 28.78 | 28.14 | 28.41 | 2.169M |
May 02, 2024 | 28.28 | 28.99 | 28.24 | 28.76 | 5.352M |
May 01, 2024 | 27.71 | 28.21 | 27.70 | 28.07 | 3.115M |
Apr 30, 2024 | 28.04 | 28.13 | 27.68 | 27.70 | 2.631M |
Apr 29, 2024 | 28.04 | 28.26 | 27.90 | 28.12 | 3.605M |
Apr 26, 2024 | 27.98 | 28.27 | 27.81 | 28.00 | 1.748M |
Apr 25, 2024 | 28.06 | 28.20 | 27.65 | 28.11 | 3.309M |
Apr 24, 2024 | 27.90 | 28.00 | 27.60 | 27.98 | 2.578M |
Apr 23, 2024 | 27.84 | 27.97 | 27.21 | 27.82 | 4.682M |
Apr 22, 2024 | 28.25 | 28.40 | 27.68 | 27.82 | 2.720M |
Apr 19, 2024 | 27.85 | 28.19 | 27.69 | 28.16 | 1.776M |
Apr 18, 2024 | 27.54 | 28.04 | 27.50 | 27.89 | 2.092M |
Apr 17, 2024 | 27.54 | 27.78 | 27.42 | 27.61 | 2.335M |
Apr 16, 2024 | 28.09 | 28.12 | 27.46 | 27.46 | 2.172M |
Apr 15, 2024 | 28.37 | 28.60 | 28.02 | 28.25 | 2.429M |
Apr 12, 2024 | 29.06 | 29.06 | 27.87 | 28.22 | 3.161M |
Apr 11, 2024 | 29.53 | 29.60 | 28.50 | 29.05 | 3.221M |
Apr 10, 2024 | 29.44 | 29.71 | 29.16 | 29.45 | 2.404M |
Apr 09, 2024 | 29.23 | 29.73 | 29.18 | 29.72 | 1.886M |
Apr 08, 2024 | 29.12 | 29.32 | 29.06 | 29.24 | 3.787M |
Apr 05, 2024 | 28.67 | 29.54 | 28.57 | 29.19 | 2.988M |
Apr 04, 2024 | 28.89 | 29.16 | 28.53 | 28.72 | 2.542M |
Apr 03, 2024 | 29.48 | 29.56 | 28.68 | 28.80 | 3.625M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
26.21
Minimum
Oct 27 2023
52.82
Maximum
Jan 26 2021
38.21
Average
39.50
Median
Nov 03 2021
Price Benchmarks
Viatris Inc | 11.81 |
Amgen Inc | 307.35 |
Arrowhead Pharmaceuticals Inc | 25.21 |
Pacira BioSciences Inc | 29.58 |
Maravai LifeSciences Holdings Inc | 8.86 |
Price Related Metrics
PE Ratio | 11.11 |
PS Ratio | 7.167 |
Price to Book Value | 1.916 |
Price to Free Cash Flow | 5.648 |
Earnings Yield | 9.00% |
Market Cap | 12.50B |
Operating PE Ratio | 11.31 |
Normalized PE Ratio | 14.03 |